Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-015904
Filing Date
2013-03-18
Accepted
2013-03-18 17:09:41
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v335949_10k.htm 10-K 1940219
2 EXHIBIT 23.1 v335949_ex23-1.htm EX-23.1 2194
3 EX-31.1 v335949_ex31-1.htm EX-31.1 10429
4 EX-31.2 v335949_ex31-2.htm EX-31.2 10446
5 EX-32.1 v335949_ex32-1.htm EX-32.1 4168
6 EX-32.2 v335949_ex32-2.htm EX-32.2 4209
7 GRAPHIC tpg38.jpg GRAPHIC 90449
  Complete submission text file 0001144204-13-015904.txt   18719655

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT scmp-20121231.xml EX-101.INS 3936919
9 XBRL TAXONOMY EXTENSION SCHEMA scmp-20121231.xsd EX-101.SCH 73818
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20121231_cal.xml EX-101.CAL 96731
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20121231_def.xml EX-101.DEF 286424
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20121231_lab.xml EX-101.LAB 624482
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20121231_pre.xml EX-101.PRE 518992
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33609 | Film No.: 13698825
SIC: 2834 Pharmaceutical Preparations